News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Justin Taylor: Roche, AbbVie Announce Trial of Venclexta in Patients with Myelodysplastic Syndromes Falls Short
clinicaloptions.com
Jun 20, 2025, 08:05

Justin Taylor: Roche, AbbVie Announce Trial of Venclexta in Patients with Myelodysplastic Syndromes Falls Short

Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared a post on X:

“Wow, big news today! Was not expecting this and leaves a big unmet need still for MDS.
Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short.”

Read Full Article.

More posts featuring Justin Taylor on OncoDaily.

AbbVie cancer Justin Taylor myelodysplastic syndromes OncoDaily Oncology Roche
Special Coverage
Blog
Jul 9, 2025, 18:36
2nd Synergies Forum Marks Milestone for Pediatric and Young Adult Cancer Advocacy in Europe - ELLOK
Insight
Jul 9, 2025, 18:16
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Blog
Jul 9, 2025, 17:59
Afreen Shariff: Ready to Take Cancer Care to New Heights?
Blog
Jul 9, 2025, 17:48
Adrian Pogacian: New Developments in Scanxiety Live Webinar
Blog
Jul 9, 2025, 17:36
Wafaa M Rashed: Ethics, Equity and Policy - Through the Eyes of a Future Leader
Blog
Jul 9, 2025, 17:21
Bernard Fox: What Do Cancer Researchers Need Today?
Blog
Jul 9, 2025, 17:21
Wafik El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development
Blog
Jul 9, 2025, 17:19
David Skorton: AAMC Viewpoint on a Fourth-Year Medical Student Who Responded to an In-Flight Medical Emergency
Blog
Jul 9, 2025, 17:11
Oliver Bogler: Essential Steps for Your Research Proposal
Blog
Jul 9, 2025, 17:09
GENIAL is Paving the Way for More Effective, Personalized Care
Blog
Jul 9, 2025, 16:58
Graham Collins: TRANSFORM Study - Liso-Cel vs Standard 2nd Line in 1st Relapse Large B-Cell NHL
Blog
Jul 9, 2025, 16:50
David Zaas: Hugh Chatham Health has Joined Atrium Health Wake Forest Baptist